Navigation Links
Pfizer Identifies Synexus' South African Clinical Research Sites as INSPIRE Sites - First in Africa
Date:6/12/2013

MANCHESTER, England, June 12, 2013 /PRNewswire/ --

Three of Synexus' South African dedicated clinical research centres Stanza, Watermeyer and Nyeleti have been identified by Pfizer as meeting the exacting standards that the company demands to join a worldwide network of INSPIRE sites which must be both highly productive and effective.

INSPIRE, which stands for Investigator Networks, Site Partnerships and Infrastructure for Research Excellence, means that these sites have early access to Pfizer's portfolio data and advanced information regarding the clinical trials to be sponsored by Pfizer. They are also involved in publications in scientific journals, protocol design, advisory boards and the sharing of best practice across the INSPIRE network.

Synexus, which is the world's largest multi-national company focused on the recruitment and running of clinical trials, already has an INSPIRE site in Wroclaw Poland.

Tebogo Sebata, Investigator Site Development and Support Lead, Pfizer Global commented, "We are really delighted that we have been able to identify these sites and add them to our INSPIRE network. We put in place the INSPIRE programme so that we can work with the best sites across the world. Centres which have real expertise in the science of clinical trials, the infrastructure support that is necessary, proven recruitment strategies and the in depth knowledge can help us maximize our development programmes going forward."

Dr Sanet Aspinall, Managing Director of Synexus South Africa, commented, "We are thrilled to have been invited to become part of the INSPIRE network. We have had to go through an exhaustive assessment programme which looked at our previous experience, expertise across a range of therapeutic areas, infrastructure and resources and effective recruitment strategies. This is not only excellent for our company but for South Africa as it shows that it is a very good place in which to carry out clinical trials."

Dr Glynis Neagle, Chief Medical Officer for Synexus concluded, "We are really focussed on providing our clients with quality patients and data. To do this, we are training our doctors and clinical staff in the medical science of the therapy areas we focus on; cardiovascular, metabolic (diabetes and obesity), bone, respiratory, infectious diseases and CNS (dementia and pain). Our investigators are experts in clinical trials and apply this knowledge to each trial which gives added value to clients."

Contact:
Simon Vane Percy
simon@vanepercy.com
+ 44-(0)1737-821-890



'/>"/>
SOURCE Synexus
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Venaxis Appoints SomaLogic CMO and former Pfizer Executive Stephen A. Williams, M.D., Ph.D., to Board of Directors
2. Over 50? Of Course Youve Still Got It, and the Y and Pfizer are Launching 50 MOVING FORWARD to Help You Keep It
3. Pipeline Initiatives, Partnerships to Drive Growth - Research Report on Pfizer, Theravance, ISIS Pharmaceuticals, Infinity Pharmaceuticals and Ironwood
4. Top Active Companies to Watch: Crown Marketing, Herbalife, Novogen, GNC, Pfizer and Infinity Pharmaceuticals
5. Free Research Report on Ford Motor Co., Pfizer, Inc., Barclays Bank PLC, General Electric Co. and PowerShares QQQ Trust
6. Block Engineering Announces Collaborative Agreement with Pfizer for Next Generation Cleaning Verification Technology
7. Cystic Fibrosis Foundation Therapeutics Announces $58 Million CF Drug Discovery Agreement with Pfizer
8. Isis To Receive $1.25 Million Payment As Pfizer Continues Development Of EXC 001
9. The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
10. VLST Corporation Announces In-licensing Agreement with Pfizer for Anti-CD40 Monoclonal Antibody
11. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)...  Endo International plc (NASDAQ: ENDP ) ... all known U.S. mesh product liability claims and that ... remaining U.S. claims at reasonable values. Under the agreements, ... quarter of 2017 and continuing through the fourth quarter ... results, the Company intends to increase its mesh product ...
(Date:8/2/2017)... AROMAS, Calif. , Aug. 2, 2017 /PRNewswire/ ... by Continental Who,s Who as a Pinnacle Lifetime ... currently the Key Account Manager at Turing Pharmaceuticals, ... communications, negotiations, troubleshooting and relationship building.                ... has more than 25 years of experience ...
(Date:8/1/2017)... Aug. 1, 2017   CerSci Therapeutics , a ... Texas , has received notice from the National ... of Health (NIH) that it has been awarded a ... over $650,000 in 2017 with an additional $1,000,000 to ... New Drug application of their lead non-opioid drug candidate ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... devices. Through an educational webinar, they will present the line of epMotion automated ... learn how easy you can automate everyday pipetting tasks. , Ideal for scientists ...
(Date:8/18/2017)... Woodlands, TX (PRWEB) , ... August 18, 2017 ... ... protection assistance and financial planning services to communities in east Texas, is launching ... Pediatric Brain Tumor Foundation. , Founded in 1991, the Pediatric Brain Tumor Foundation ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... The Golseth ... in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized to provide ... , In early June of this year, Christina and her children returned from out ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that rids the body ... with its product now available through Jet.com. , After 25 years of development, ... drink is designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re ...
Breaking Medicine News(10 mins):